Publications by authors named "T Jourdan"

Claim this Profile
L
Log-time algorithms for exact stochastic simulation of fully connected reaction networks using low-rank decomposition and rejection sampling.
Rohit Vasav, Thomas Jourdan, Gilles Adjanor, Manuel Athènes

J Chem Phys· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blockade of cannabinoid CB receptors potentiates the anti-fibrotic effects mediated by SGLT2 inhibition in a mouse model of diabetic nephropathy.
Océane Pointeau, Awa Isma Ba, Audrey Geissler, Romain Barbosa, Abhishek Basu, Tony Jourdan

Br J Pharmacol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leveraging Peripheral CB1 Antagonism in 1,4,5,6-Tetrahydropyridazine-Based Amidine Substituted Sulfonyl Analogs for Treating Metabolic Disorders.
Pinaki Bhattacharjee, Szabolcs Dvorácskó, Paul Volesky, Océane Pointeau, Nicholas Rutland, Tony Jourdan

J Med Chem· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of tetrahydropyridazine-based peripherally restricted dual inhibitors of CB1R and inducible nitric oxide synthase (iNOS) for treating metabolic syndrome disorders.
Pinaki Bhattacharjee, Szabolcs Dvorácskó, Océane Pointeau, Biswajit Kundu, Nicholas Rutland, Tony Jourdan

Metabolism· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting cannabinoid receptor 1 for antagonism in pro-fibrotic alveolar macrophages mitigates pulmonary fibrosis.
Abhishek Basu, Muhammad Arif, Kaelin M Wolf, Madeline Behee, Natalie Johnson, Tony Jourdan

JCI Insight· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis